Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta‐analysis and systemic review

Measuring inconsistency in meta-analyses

Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139

Bias in meta-analysis detected by a simple, graphical test

Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722

Quantifying heterogeneity in a meta‐analysis

Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011

Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>

Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623

International Diabetes Federation 2017

Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418

Estimating the mean and variance from the median, range, and the size of a sample

Hozo, S. P., Djulbegovic, B., & Hozo, I. (2005) · BMC Medical Research Methodology · doi:10.1186/1471-2288-5-13 · Cited by 9,062

Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme

Revollo, J. R., Körner, A., Mills, K. F., Satoh, A., Wang, T., Garten, A., Dasgupta, B., Sasaki, Y., Wolberger, C., Townsend, R. R., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.003 · Cited by 911

Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin

Curat, C. A., Wegner, V., Sengenès, C., Miranville, A., Tonus, C., Busse, R., & Bouloumié, A. (2006) · Diabetologia · doi:10.1007/s00125-006-0173-z · Cited by 693

Elevated Plasma Level of Visfatin/Pre-B Cell Colony-Enhancing Factor in Patients with Type 2 Diabetes Mellitus

Chen, M.-P., Chung, F.-M., Chang, D.-M., Tsai, J. C.-R., Huang, H.-F., Shin, S.-J., & Lee, Y.-J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1475 · Cited by 660

Increased Expression of Visfatin in Macrophages of Human Unstable Carotid and Coronary Atherosclerosis: Possible Role in Inflammation and Plaque Destabilization

Dahl, T. B., Yndestad, A., Skjelland, M., Øie, E., Dahl, A., Michelsen, A., Damås, J. K., Tunheim, S. H., Ueland, T., Smith, C., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.665893 · Cited by 465

Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-κB activation in endothelial cells

Kim, S.-R., Bae, Y.-H., Bae, S.-K., Choi, K.-S., Yoon, K.-H., Koo, T. H., Jang, H.-O., Yun, I., Kim, K.-W., Kwon, Y.-G., et al. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.004 · Cited by 316

Skeletal muscle NAMPT is induced by exercise in humans

Costford, S. R., Bajpeyi, S., Pasarica, M., Albarado, D. C., Thomas, S. C., Xie, H., Church, T. S., Jubrias, S. A., Conley, K. E., & Smith, S. R. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00318.2009 · Cited by 296

Reduced Plasma Visfatin/Pre-B Cell Colony-Enhancing Factor in Obesity Is Not Related to Insulin Resistance in Humans

Pagano, C., Pilon, C., Olivieri, M., Mason, P., Fabris, R., Serra, R., Milan, G., Rossato, M., Federspil, G., & Vettor, R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0361 · Cited by 295

Changes and Relations of Circulating Visfatin, Apelin, and Resistin Levels in Normal, Impaired Glucose Tolerance, and Type 2 Diabetic Subjects

Li, L., Yang, G., Li, Q., Tang, Y., Yang, M., Yang, H., & Li, K. (2006) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2006-948309 · Cited by 268

The release of the adipocytokine visfatin is regulated by glucose and insulin

Haider, D. G., Schaller, G., Kapiotis, S., Maier, C., Luger, A., & Wolzt, M. (2006) · Diabetologia · doi:10.1007/s00125-006-0303-7 · Cited by 258

Serum Visfatin Increases With Progressive β-Cell Deterioration

López-Bermejo, A., Chico-Julià, B., Fernàndez-Balsells, M., Recasens, M., Esteve, E., Casamitjana, R., Ricart, W., & Fernández-Real, J.-M. (2006) · Diabetes · doi:10.2337/db06-0259 · Cited by 216

Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance

Dogru, T., Sonmez, A., Tasci, I., Bozoglu, E., Yilmaz, M. I., Genc, H., Erdem, G., Gok, M., Bingol, N., Kilic, S., et al. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.07.031 · Cited by 201

Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus

Takebayashi, K., Suetsugu, M., Wakabayashi, S., Aso, Y., & Inukai, T. (2007) · Metabolism · doi:10.1016/j.metabol.2006.12.001 · Cited by 174

Molecular Characteristics of Serum Visfatin and Differential Detection by Immunoassays

Körner, A., Garten, A., Blüher, M., Tauscher, R., Kratzsch, J., & Kiess, W. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1304 · Cited by 159

Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians

Sandeep, S., Velmurugan, K., Deepa, R., & Mohan, V. (2007) · Metabolism · doi:10.1016/j.metabol.2006.12.005 · Cited by 158

Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes

Garten, A., Petzold-Quinque, S., Barnikol-Oettler, A., Körner, A., Thasler, W. E., Kratzsch, J., Kiess, W., & Gebhardt, R. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.066 · Cited by 153

Visfatin Is an Adipokine, But It Is Not Regulated by Thiazolidinediones

Hammarstedt, A., Pihlajamäki, J., Sopasakis, V. R., Gogg, S., Jansson, P., Laakso, M., & Smith, U. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1395 · Cited by 153

Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity

Romacho, T., Azcutia, V., Vázquez-Bella, M., Matesanz, N., Cercas, E., Nevado, J. B., Carraro, R., Rodríguez‐Mañas, L., Sánchez‐Ferrer, C. F., & Peiró, C. (2009) · Diabetologia · doi:10.1007/s00125-009-1509-2 · Cited by 150

The novel adipocytokine visfatin exerts direct cardioprotective effects

Lim, S. Y., Davidson, S. M., Paramanathan, A. J., Smith, C., Yellon, D. M., & Hausenloy, D. J. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00332.x · Cited by 148

Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease

Choi, K. M., Lee, J. S., Kim, E. J., Baik, S. H., Seo, H. S., Cho, Y., Oh, D. J., & Park, C. G. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0633 · Cited by 141

Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans

Liu, S. W., Qiao, S. B., Yuan, J. S., & Liu, D. Q. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03453.x · Cited by 136

Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus

EL-Mesallamy, H. O., Kassem, D. H., El‐Demerdash, E., & Amin, A. I. (2010) · Metabolism · doi:10.1016/j.metabol.2010.04.008 · Cited by 135

Nuclear Factor-κB Induction by Visfatin in Human Vascular Endothelial Cells

Adya, R., Tan, B. K., Chen, J., & Randeva, H. S. (2008) · Diabetes Care · doi:10.2337/dc07-1544 · Cited by 135

Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis

Zhong, M., Tan, H., Gong, H., Wang, S., Zhang, Y., & Zhang, W. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03248.x · Cited by 130

Serum concentration of visfatin in obese women

Zahorska‐Markiewicz, B., Olszanecka‐Glinianowicz, M., Janowska, J., Kocełak, P., Semik-Grabarczyk, E., Holecki, M. T., Dąbrowski, P., & Skorupa, A. J. (2007) · Metabolism · doi:10.1016/j.metabol.2007.04.007 · Cited by 129

Visfatin regulates insulin secretion, insulin receptor signalling and mRNA expression of diabetes-related genes in mouse pancreatic β-cells

Brown, J. E. P., Onyango, D., Ramanjaneya, M., Conner, A. C., Patel, S. T., Dunmore, S., & Randeva, H. S. (2009) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0071 · Cited by 126

Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome

Filippatos, T. D., Derdemezis, C. S., Kiortsis, D. N., Tselepis, A. D., & Elisaf, M. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03346300 · Cited by 118

Serum visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by overfeeding in healthy young men

Sun, G., Bishop, J., Khalili, S., Vasdev, S., Gill, V. D., Pace, D., Fitzpatrick, D., Randell, E. W., Xie, Y., & Zhang, H. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.2.399 · Cited by 117

Effect of Weight Loss on Proinflammatory State of Mononuclear Cells in Obese Women

Sheu, W. H., Chang, T., Lee, W., Ou, H., Wu, C.-M., Tseng, L., Lang, H.-F., Wu, C., Wan, C., & Lee, I. (2008) · Obesity · doi:10.1038/oby.2008.37 · Cited by 112

Effect of exercise training on plasma visfatin and eotaxin levels

Choi, K. M., Kim, J. H., Cho, G. J., Baik, S. H., Park, H. S., & Kim, S. M. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0127 · Cited by 112

Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin

Yılmaz, M. İ., Sağlam, M., Qureshi, A. R., Carrero, J. J., Çağlar, K., Eyileten, T., Sönmez, A., Cakir, E., Oğuz, Y., Vural, A., et al. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm828 · Cited by 111

Borrowing from Biology

Nazar, R. N., & Robb, E. J. (2007) · Science · doi:10.1126/science.318.5850.565c · Cited by 109

The visfatin gene is associated with glucose and lipid metabolism in a Chinese population

Jian, W., Luo, T. ‐., Gu, Y., Zhang, H. ‐., Zheng, S., Dai, M., Han, J., Zhao, Y. Y., Li, G., & Luo, M. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01909.x · Cited by 97

Visfatin (Nampt) and Ghrelin as Novel Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes

Kadoglou, N. P. E., Sailer, N., Moumtzouoglou, A., Kapelouzou, A., Tsanikidis, H., Vitta, I., Karkos, C. D., Karayannacos, P., Gerasimidis, T., & Liapis, C. D. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1237360 · Cited by 93

Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function

Faßhauer, M., Blüher, M., Stümvoll, M., Tönnessen, P., Faber, R., & Stepan, H. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02751.x · Cited by 87

Correlation of circulating full‐length visfatin (PBEF/NAMPT) with metabolic parameters in subjects with and without diabetes: a cross‐sectional study

Retnakaran, R. R., Youn, B., Liu, Y., Hanley, A. J., Lee, N. S., Park, J. W., Song, E. S., Vu, V. P., Kim, W. I., Tungtrongchitr, R., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03264.x · Cited by 82

Epicardial fat thickness: Relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity

Malavazos, A. E., Ermetici, F., Cereda, E., Coman, C., Locati, M., Morricone, L. F., Romanelli, M. M. C., & Ambrosi, B. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.09.001 · Cited by 79

The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women

Chen, C., Li, T., Li, C.-I., Liu, C.-S., Lin, W., Wu, M., Lai, M.-M., & Lin, C. (2007) · Metabolism · doi:10.1016/j.metabol.2007.04.018 · Cited by 77

Relationship Between Cerebrospinal Fluid Visfatin (PBEF/Nampt) Levels and Adiposity in Humans

Hallschmid, M., Randeva, H. S., Tan, B. K., Kern, W., & Lehnert, H. (2008) · Diabetes · doi:10.2337/db08-1176 · Cited by 75

Elevated Visfatin/Pre-B-cell Colony-enhancing Factor Plasma Concentration in Ischemic Stroke

Lu, L.-F., Yang, S.-S., Wang, C.-P., Hung, W., Yu, T., Chiu, C., Chung, F., Shin, S., & Lee, Y. (2009) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2009.01.003 · Cited by 73

Increase in visfatin after weight loss induced by gastroplastic surgery

Krzyzanowska, K., Mittermayer, F., Krugluger, W., Kopp, H. P., & Schernthaner, G. (2006) · Obesity · doi:10.1038/oby.2006.219 · Cited by 71

The circulating PBEF/NAMPT/visfatin level is associated with a beneficial blood lipid profile

Wang, P., van Greevenbroek, M. M. J., Bouwman, F. G., Brouwers, M. C. G. J., Kallen, C., Smit, E., Keijer, J., & Mariman, E. C. M. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-007-0262-y · Cited by 68

Circulating Visfatin Is Associated With Parameters of Iron Metabolism in Subjects With Altered Glucose Tolerance

Fernández‐Real, J. M., Moreno‐Navarrete, J. M., Chico, B., López‐Bermejo, A., & Ricart, W. (2007) · Diabetes Care · doi:10.2337/dc06-1581 · Cited by 59

Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistance and obesity

Esteghamati, A., Alamdari, A., Zandieh, A., Elahi, S., Khalilzadeh, O., Nakhjavani, M., & Meysamie, A. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.11.003 · Cited by 56

Plasma visfatin levels in normal weight women with polycystic ovary syndrome

Panidis, D., Farmakiotis, D., Rousso, D., Katsikis, I., Delkos, D., Piouka, A., Gerou, S., & Diamanti‐Kandarakis, E. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2007.05.014 · Cited by 55

Relation of adiponectin, visfatin and bone mineral density in patients with metabolic syndrome

Iacobellis, G., Iorio, M. D., Napoli, N., Cotesta, D., Zinnamosca, L., Marinelli, C., Petramala, L., Minisola, S., D'Erasmo, E., & Letizia, C. (2011) · Journal of Endocrinological Investigation · doi:10.1007/bf03346703 · Cited by 53

Visfatin is upregulated in type-2 diabetic rats and targets renal cells

Kang, Y. S., Song, H. K., Lee, M., Ko, G. J., Han, J., Han, S. Y., Han, K. H., Kim, H. K., & Cha, D. R. (2010) · Kidney International · doi:10.1038/ki.2010.98 · Cited by 49

Adipokines and cardiometabolic function: How are they interlinked?

Schutte, A. E., Huisman, H. W., Schutte, R., van Rooyen, J. M., Malan, L., Fourie, C. M. T., & Malan, N. T. (2010) · Regulatory Peptides · doi:10.1016/j.regpep.2010.06.008 · Cited by 41

Plasma concentration of visfatin is a new surrogate marker of systemic inflammation in type 2 diabetic patients

Kang, Y. S., Song, H. K., Lee, M., Ko, G. J., & Cha, D. R. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.03.020 · Cited by 40

Plasma visfatin levels are positively associated with circulating interleukin-6 in apparently healthy Korean women

Seo, J. A., Jang, E. S., Kim, B. G., Ryu, O. H., Kim, H. Y., Lee, K. W., Kim, S. G., Choi, K. M., Baik, S. H., Cho, Y., et al. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.04.016 · Cited by 38

Adipokine Profile and Insulin Sensitivity in Formerly Obese Women Subjected to Bariatric Surgery or Diet-Induced Long-term Caloric Restriction

Mitterberger, M. C., Mattesich, M., Klaver, E., Lechner, S., Engelhardt, T. O., Larcher, L., Pierer, G., Piza‐Katzer, H., & Zwerschke, W. (2010) · The Journals of Gerontology Series A · doi:10.1093/gerona/glq107 · Cited by 37

Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy

Alghasham, A., & Barakat, Y. A. (2008) · Saudi Medical Journal · doi:10.15537/1658-3175.4217 · Cited by 36

Preanalytical influences on the measurement of visfatin by enzyme immuno assay

Nüsken, K., Nüsken, E., Petrasch, M., Rauh, M., & Dötsch, J. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.04.004 · Cited by 34

Relationship between serum retinol-binding protein 4 and visfatin and the metabolic syndrome

Lin, C., Lai, M.-M., Li, T., Li, C.-I., Liu, C.-S., Chen, C., & Wu, M. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.03.016 · Cited by 33

Serum retinol-binding protein 4 concentrations in response to short-term overfeeding in normal-weight, overweight, and obese men

Shea, J. L., Randell, E. W., Vasdev, S., Wang, P., Roebothan, B., & Sun, G. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1310 · Cited by 30

Visfatin expression in subcutaneous adipose tissue of pre‐menopausal women: relation to hormones and weight reduction

Kováčiková, M., Vitkova, M., Klimčáková, E., Polak, J., Hejnová, J., Bajzová, M., Kováčová, Z., Viguerie, N., Langin, D., & Štich, V. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.01964.x · Cited by 28

Intensive Glycemic Control Lowers Plasma Visfatin Levels in Patients with Type 2 Diabetes

Zhu, J., Schott, M., Liu, R., Liu, C., Shen, B., Wang, Q., Mao, X., Xu, K., Wu, X., Schinner, S., et al. (2008) · Hormone and Metabolic Research · doi:10.1055/s-0028-1082040 · Cited by 27

The relationship between visfatin and metabolic syndrome in postmenopausal women

Kim, J., Kim, S.-H., Im, J., & Lee, D. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.05.002 · Cited by 24

Dynamics of Nampt/visfatin and high molecular weight adiponectin in response to oral glucose load in obese and lean women

Ünlütürk, U., Harmancı, A., Yıldız, B. O., & Bayraktar, M. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03674.x · Cited by 23

Effect of renin–angiotensin–aldosterone system (RAAS) blockade on visfatin levels in diabetic nephropathy

Eyileten, T., Sönmez, A., Sağlam, M., Çakır, E., Çağlar, K., Oğuz, Y., Vural, A., Yenicesu, M., & Yılmaz, M. İ. (2009) · Nephrology · doi:10.1111/j.1440-1797.2009.01173.x · Cited by 22

NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential

Xie, N., Zhang, L., Gao, W., Huang, C., Huber, P. E., Zhou, X., Li, C., Shen, G., & Zou, B. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00311-7 · Cited by 1,052

Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence

Rajman, L., Chwalek, K., & Sinclair, D. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.011 · Cited by 865

Physiological and pathophysiological roles of NAMPT and NAD metabolism.

Garten, A., Schuster, S., Penke, M., Gorski, T., de Giorgis, T., & Kiess, W. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.117 · Cited by 708

Adipose tissue, obesity and adipokines: role in cancer promotion

Booth, A., Magnuson, A., Fouts, J., & Foster, M. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0037 · Cited by 329

Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin

Piya, M. K., McTernan, P. G., & Kumar, S. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0498 · Cited by 264